MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
NOVO.B.DK Novo Nordisk A/S Class B 76.4 ¤343,661 DK
MC.FR LVMH Moet Hennessy Louis Vuitton SE 43.9 ¤337,333 FR
RO.CH Roche Holding Ltd 57.6 ¤282,505 CH
ASML.NL ASML Holding NV 77.1 ¤270,570 NL
AZN.GB AstraZeneca PLC 70.5 ¤230,780 GB

Five Smallest Companies
Symbol Name Grade Market Cap Country
GALP.PT Galp Energia, SGPS S.A. Class B 52.3 ¤11,971 PT
APTV Aptiv PLC 63.4 ¤14,499 CH
SY1.DE Symrise AG 58.7 ¤14,518 DE
REP.ES Repsol SA 39.1 ¤14,606 ES
NXT.GB Next plc 59.9 ¤14,900 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 77.1 31 NL
ACN Accenture Plc Class A 65.1 30 IE
DNB.NO DNB Bank ASA 72.5 27 NO
LR.FR Legrand SA 63.4 27 FR
ALV.DE Allianz SE 58.2 26 DE
NOVO.B.DK Novo Nordisk A/S Class B 76.4 26 DK
ASSA.B.SE ASSA ABLOY AB Class B 57.0 25 SE
TEL TE Connectivity plc 54.8 24 IE
ETN Eaton Corp. Plc 59.8 23 IE
VOLV.B.SE Volvo AB Class B 62.5 23 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤66,921
Median Market Cap ¤41,443
Avg. 3 Mo. Dollar Vol. ¤152,025,749
Avg. 3 Mo. Trading Vol. 5,627,242
Last Rebalance Date 09/23/2024
Companies Replaced 33
Biggest Sector Increase Technology
Biggest Sector Decrease Materials

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 15.8
Forward P/E Ratio (12 Mo.) 13.5
Price/Book Ratio 2.5
Avg. Revenue Chg. - 3 Yr 32.0%
Avg. Op. Income Chg. - 3 Yr. 43.4%
Avg. EPS Growth - 3 Yr. 13.8%
Avg. EPS Growth - 1 Yr. 12.3%
Avg. Operating Margin 18.6%
Avg. LT Debt to Total Capital 41.7%
Avg. Return on Equity 16.9%
Dividend Yield 2.2%
Index Average Grade
Europe 100 Index 57.35
Country Breakdown
United Kingdom 17.0%
France 13.0%
Switzerland 12.0%
Germany 11.0%
Spain 9.0%
Ireland 9.0%
Sweden 8.0%
Netherlands 6.0%
Italy 6.0%
Norway 3.0%
Denmark 2.0%
Finland 1.0%
Luxembourg 1.0%
Portugal 1.0%
Austria 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE